2021
DOI: 10.1039/d1ra05492a
|View full text |Cite
|
Sign up to set email alerts
|

Simultaneous determination of Avanafil and Dapoxetine in human plasma using liquid chromatography/tandem mass spectrometry (LC-MS/MS) based on a protein precipitation technique

Abstract: A rapid and selective LC-MS/MS method is described for the simultaneous assay of Avanafil and Dapoxetine in human plasma via a protein precipitation (PP) sample preparation technique.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 37 publications
0
3
0
Order By: Relevance
“…The LLOQ is the lowest amount of an analyte that can be quantitatively determined with acceptable precision and accuracy (the accuracy should be ±20% of nominal and the precision should be ±20% RSD). 30–32 The LLOQs were 1 μg mL −1 . The limit of detection (LOD) refers to the minimum amount of a substance that can be detected.…”
Section: Resultsmentioning
confidence: 99%
“…The LLOQ is the lowest amount of an analyte that can be quantitatively determined with acceptable precision and accuracy (the accuracy should be ±20% of nominal and the precision should be ±20% RSD). 30–32 The LLOQs were 1 μg mL −1 . The limit of detection (LOD) refers to the minimum amount of a substance that can be detected.…”
Section: Resultsmentioning
confidence: 99%
“…Table 1, [49][50][51][52][53][54][55] indicated analytical results of different reports for the detection of DPX as can be seen, various biomedical methods such as HPLC-MS, HPLC-MS/MS, LC-MS/MS, spectrophotometric, uorometric, UPLC-MS, UPLC-MS/MS, have been utilized for the monitoring of DPX.…”
Section: Repeatability and Reproducibilitymentioning
confidence: 99%
“…AVN is particularly popular because it operates quickly and has few visible adverse effects compared with the other inhibitors of PDE5 [ 2 ]. AVN, (S)-4-((3-chloro-4-methoxybenzyl) amino)-2-(2-(hydroxymethyl) pyrrolidin-1-yl)-N-(pyrimidin-2-ylmethyl) pyrimidine-5- carboxamide is shown in Scheme 1 [ 3 ]. Specifically, AVN blocks the action of the PDE5 enzyme.…”
Section: Introductionmentioning
confidence: 99%